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ABSTRACT 
Genetic variants that spread along the human genome play vital roles in determining our 
traits, affecting development and potentially causing disorders. Most common disorders have 
complex underlying mechanisms involving genetic or environmental factors and the 
interaction between them. Over the past decade, genome-wide association studies (GWAS) 
have identified thousands of common variants that contribute to complex disorders and 
partially explain the heritability. However, there is still a large portion that is unexplained and 
the missing heritability may be caused by several factors, such as rare or low-frequency 
variants with high effect that are not covered by GWAS and linkage analysis. With the 
development of next generation sequencing (NGS), it is possible to rapidly detect large 
amount of novel rare and low-frequency variants simultaneously at a low cost. This new 
technology provides vast information on studying the association of genetic variations and 
complex disorders. Once the susceptibility gene is mapped, model organisms such as 
zebrafish (Danio rerio) are popular for further investigating the possible function of disease-
associated gene in determining the phenotype. However, the genome annotation of zebrafish 
is not complete, which affects the characterization of gene functions. Accordingly, high-
throughput RNA sequencing can be employed for identifying new transcripts. 
In our studies, pooled DNA samples were used for whole genome sequencing (WGS) and 
exome sequencing. In Paper I, we evaluated minor allele frequency (MAF) estimates using 
three variant detection tools with two sets of pooled exome sequencing and one set of pooled 
WGS data. The MAFs from the pooled sequencing data demonstrated high concordance (r = 
0.88-0.94) with those from the individual genotyping data. In Paper II, exome sequencing 
implementing pooling strategy was performed on 100 idiopathic scoliosis (IS) patients for 
mapping susceptibility genes. After validating 20 candidate single nucleotide variants 
(SNVs), we did not find associations between them and IS. However, the previously reported 
common variant rs11190870 near LBX1 was validated in a large Scandinavian cohort. In 
Paper III, we analyzed WGS of pooled DNA samples performed on 19 affected individuals 
who shared a phenotype-linked haplotype in a dyslexic Finish family. Two of the individuals 
were sequenced for the whole genome individually as well. The screen for causative variants 
was narrowed down to a rare SNV, which might affect the binding affinity of LHX2 that 
regulated dyslexia associated gene ROBO1. In Paper IV, RNA sequencing (RNA-seq) data 
were analyzed for identifying novel transcripts in zebrafish early development using an in-
house pipeline. We discovered 152 novel transcribed regions (NTRs), validated more than 10 
NTRs and quantified their expression in early developmental stages. 
In our studies, we evaluated and applied a pooling approach for identifying variants 
susceptible to disease using high-throughput DNA sequencing. Based on RNA sequencing 
data, we provided new information for genome annotation on model organism zebrafish, 
which is valuable for studying the function of disease causative genes. In summary, the whole 
series of studies demonstrate how NGS can be applied in studying the genetic basis of 
complex disorders and assisting in follow-up functional studies in model organisms.  
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1 BACKGROUND 
“Like father, like son” is probably the best-fitting proverb to describe heredity. Nowadays, 
almost everyone knows the causation of such patterns is inheritance. What are the factors in 
determining the variation of inherited characteristics? The first recorded successful attempt to 
answer the question is from Gregor Mendel, who discovered the law of inheritance and the 
heredity units, now called “genes”. Genes, lying on the double helix of DNA strands, are 
composed of four basic elements -- two purines, adenine (A) and guanine (G), and two 
pyrimidines, thymine (T) and cytosine (C). The combination and order of the four nucleotides 
cause the diversity of characters and traits in human beings. After the launch of the Human 
Genome Project (HGP) and release of the human genome sequence (Consortium, 2004; 
Lander et al., 2001; Venter et al., 2001), we have a clearer vision of the genes encoded in the 
human genome. At the same time, powerful bioinformatics software have been developed to 
decode the hidden messages written in our genome. The complete reference sequence and 
new tools allow us to dig more deeply into genomes for identifying the genes corresponding 
to or associated with specific phenotypes, especially disorders. 
1.1 GENETIC VARIATIONS 
The completion of the HGP revealed the sequences of 3 billion base pairs DNA, and more 
than 25,000 protein coding genes. Over 99% of DNA sequences in the human genome are 
consistent, while thousands of genetic variations have been observed across the human 
genome. We can divide them into different types based on their sizes: small-scale sequencing 
variation and large-scale structural variation. 
1.1.1 Different types of genetic variations 
The largest group of small-scale sequencing variations is the single nucleotide variant (SNV) 
(Figure 1a). An SNV is described as a substitution of a single nucleotide. DNA substitutions 
are classified as transitions (between two purines or two pyrimidines) and transversions 
(interchanges of purines for pyrimidines). The majority of the single base pair variations can 
have two forms of alleles, either transition or transversion. However, some polymorphic sites 
may be complex, e.g. three to four alternative alleles. SNVs with frequency in population of 
over 1% were termed as single nucleotide polymorphisms (SNPs). A total number of 1.42 
million SNPs were identified in the human genome draft (Sachidanandam et al., 2001). In 
addition to SNVs, short insertions or deletions (INDELs) and short repeats distribute across 
all or part of the genome (Figure 1b). An INDEL is a deleted base(s) or extra inserted base(s) 
ranging from 1 bp to 1 kb in DNA sequencing. Tandem repeats are one kind of short repeats 
and can be divided into three categories according to the length of repeat units: satellites 
(over 50 bp), minisatellites (10-50 bp) and microsatellites (less than 10 bp). Most 
microsatellites have repeats of one to four nucleotides. 
Large-scale structural variations (SVs) can be defined as the rearrangement of segments over 
1kb (Feuk et al., 2006). Some major structurally abnormal variants include copy number 
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variations (CNVs), inversions and translocations (Figure 1b). CNVs represent deletions, 
insertions or duplications of long tandemly repeated sequences. Although SNPs are most 
abundant in the genome, structural variations actually affect more numbers of nucleotides. 
 
Figure 1. Different types of genetic variations a) Small-scale sequencing variation, b) Large-scale 
structural variation. Each color block represents a long DNA sequencing over 1kb. 
1.1.2 Effects 
A single nucleotide substitution in coding regions can change the encoded protein sequence, 
such as a missense variant. A nonsense mutation generates a stop codon and truncates the 
protein. A silent variant usually alters DNA sequences but not protein sequences. The point 
variants that can change the protein sequence are classified as non-synonymous variants, 
while those that do not affect protein sequence are synonymous variants. Any coding INDEL 
with a size at a non-integral number of codon causes a shift of open reading frame (ORF), 
consequently altering the protein sequence. Alternative splicing of primary transcripts can be 
Single nucleotide variant  
Small deletion 
Small insertion 
A T G T T G A T G C C T
A T G T T G C T G C C T
A T G T T G        G C C T
A T G T T G ATT G C C T
Copy number variation 
Reference sequence 
Reference sequence 
Inversion 
Large insertion 
Large deletion 
Translocation 
Reference sequences 
Short tandem repeats A T G T T G A T A T A T A T A T A T G C C T
a
b
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affected by both SNVs and INDELs located near the splicing site. A large-scale structure 
variation will lead to loss dysfunction or duplication of the genes harbored in the SV regions. 
The genetic variations at non-coding regions may change the binding of transcription factors 
or regulation elements and DNA methylation, thus affecting the gene expression nearby. 
There are more than 3 million genetic variants in two published individual diploid genomes 
(Levy et al., 2007; Wheeler et al., 2008). According to evolution, most of the variants in the 
human genome are harmless and do not have known effect on phenotypic traits. Certain 
genetic variations endow individual person with specific characteristics, e.g. skin color and 
eye color, body height and blood type. However, others may produce loss or gain of functions 
and result in disorder or susceptibility to diseases. For example, sickle cell disease and cystic 
fibrosis are determined by genetic variants in a single gene. 
1.2 DISORDERS 
1.2.1 Monogenic disorders 
A disorder governed by a single gene with a clear pattern of Mendelian inheritance is called a 
monogenic (Mendelian) disorder. The two diseases mentioned in 1.1.2 are typical examples 
of monogenic disorders. There are five basic modes of Mendelian inheritance patterns: 
autosomal dominant, autosomal recessive, X-linked dominant, X-linked recessive and Y-
linked. In recessive mode, the phenotype is only expressed when the underlying locus is 
homozygous. In dominant mode, the phenotype is expressed as long as the underlying locus 
is heterozygous. 
1.2.2 Complex disorders 
The inheritance of most common disorders does not always follow Mendelian patterns. 
Disorders may be governed by multiple genetic loci and environmental factors, therefore 
defined as complex or multifactorial disorders. For example, most early on-set Alzheimer 
patients are caused by any mutation in genes PSEN1, PSEN2 or APP in a autosomal 
dominant inheritance pattern (Bateman et al., 2012), while sporadic cases are affected by the 
environment as well (Gatz M et al., 2006). Complex disorders are usually determined by 
several gene loci with small effect (polygenic inheritance) or one locus with a major effect on 
the phenotype, modified by other genes with minor effects (oligogenic inheritance). Two 
complex disorders involved in the studies in this thesis are described below. 
1.2.2.1 Idiopathic scoliosis 
Scoliosis is a three-dimensional deformity of the spine as a lateral curvature of the spine in 
the coronal plane of more than 10° (Terminology Committee of the Scoliosis Research 
Society, 1976). It is usually classified into three major types: congenital (spinal abnormity at 
birth), syndromic (typically related neuromuscular, skeletal or connective tissue disorders) 
and idiopathic (causes unknown) (Altaf et al., 2013). 
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Idiopathic scoliosis (IS) constitutes the largest subgroup of human spinal curvatures (Gorman 
et al., 2012) and affects approximately 2-3% of the population worldwide (Luk et al., 2010; 
Rogala et al., 1978; Willner and Udén, 1982). The onset age can range from infant to 
adolescent, especially developing in childhood and adolescence. In a school-screen program, 
if there is a rib hump visible during an Adam’s forward bend test, the individual will be sent 
for an X-ray. The clinical diagnosis of scoliosis is confirmed by a standing spinal radiograph 
showing a lateral curvature of the spine over 10 degrees. Even though the etiology of IS is 
poorly understood, heredity is recognized as an important contribution factor to it (Grauers et 
al., 2012; Wynne-Davies, 1968). 
1.2.2.2 Developmental dyslexia 
Dyslexia refers to a difficulty in reading and writing, in despite of normal senses, intelligence, 
and adequate education. It can be classified into two types: acquired dyslexia (caused by 
brain damage) and developmental dyslexia (DD). The typical symptoms of DD include 
spelling errors, slow naming of letters and words and poor verbal short-term memory. They 
can be mostly covered by phonological deficits (Ramus and Szenkovits, 2008). According to 
the epidemiological reports in the 1990s, the prevalence rates of DD range from 5 to 10% and 
possibly even to 17.5% (Shaywitz, 1998). It is the most common learning disability in 
childhood and may be diagnosed at school age after parents or teachers notice difficulties in 
reading and writing. The diagnosis test for dyslexia measures a series of reading-related 
cognitive skills, involving phonological decoding, phonological awareness, orthographic 
coding, rapid automatic naming, word recognition and spelling (Francks et al., 2002). 
In addition to gender, environmental factors and co-occurrences with many other 
neurodevelopmental disorders (Friend et al., 2008; Gilger et al., 1992; Katusic et al., 2001; 
Paracchini, 2011; Rutter M et al., 2004), genetic factors are recognized as playing an 
important role in the etiology of dyslexia. Several twin studies demonstrate almost twice the 
concordance in monozygotic twins than that in dizygotic twins, suggesting a significant 
genetic component in dyslexia (Bakwin, 1973; DeFries et al., 1987; Harlaar et al., 2005; 
Hawke et al., 2006; Stevenson et al., 1987). In general, dyslexia shows complex genetic 
patterns: incomplete penetrance (Fagerheim et al., 1999), phenocopy (Nopola-Hemmi et al., 
2001), heterogeneity of susceptibility loci in different families and polygenic influence 
(Fisher and DeFries, 2002). 
1.3 GENE MAPPING IN DISORDERS 
The crossover of homologous chromosomes usually occurs during prophase of meiosis I, 
causing recombination. In principle, the loci physically nearby are less likely to be segregated 
during recombination. Gene mapping aims to identify the underlying determinants of 
phenotypes based on co-segregation pattern of all loci, which are also called genetic markers. 
Some genetic variations, e.g. microsatellite and SNP (described in 1.1.1), are used as markers 
for gene mapping. 
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1.3.1 Linkage analysis 
Linkage analysis focuses on the likelihood of recombination fraction between two loci in a 
family. The achievement of such analysis requires three parameters: a clear pattern of 
inheritance, highly polymorphic marker and penetrance of each genotype. Such test is called 
parametric analysis. In the late 20th century, microsatellites were employed as genetic 
markers in linkage studies. They were replaced by SNP arrays that can test much denser 
genetic markers along the genome simultaneously. Parametric analysis succeeds in mapping 
disease locus in monogenic disorders that show clear Mendelian inheritance patterns. 
However, it is very difficult to map susceptibility loci to complex disorders because the 
genotype and phenotype usually are in incomplete correspondence (Altmüller et al., 2001). 
To overcome this problem, a different approach is to seek the chromosomal segments shared 
by affected members in the family regardless of inheritance pattern. Since the genetic mode 
parameter is missing in the analysis, this approach is called non-parametric analysis. 
In the case of DD, most cases show a pattern of complex traits. However, some large or 
multiple small families displayed Mendelian inheritance patterns. Accordingly a series of 
genetic linkage studies have been performed (Kere, 2011). By far, nine gene loci were 
pinpointed and considered as dyslexia susceptibilities in the OMIM database 
(http://omim.org/). In a linkage study of a three-generation Finnish dyslexic family, a 33 Mb 
region (3p12-q13) on chromosome 3 was found to be associated with dyslexia (Nopola-
Hemmi et al., 2001). The same region (3q13) was supported by a genome-wide scan on 
dyslexic families in the US (Fisher et al., 2002). The susceptibility loci on chromosome 3 
were later reported to be linked to speech-sound disorder (Stein et al., 2004). Follow-up 
studies investigating the linkage region indicated ROBO1 as a susceptibility gene for dyslexia 
(Hannula-Jouppi et al., 2005; Lamminmäki et al., 2012). 
1.3.2 Association studies 
Another approach to reveal the incomplete relationship between genotype and phenotype is 
association study. The rationale of association study is based on linkage disequilibrium (LD), 
which is a non-random association of allele at two or more loci. As a result of linkage 
analysis on complex disorders, the susceptibility loci may be several Mb, which normally 
harbor many genes. For this reason, extra work and effort on studying the candidate genes in 
the loci need to be addressed. The association study is usually performed on a group of 
unrelated affected individuals and a group of unrelated controls. If there is an association 
between a phenotype and genotype, the probability of seeing the specific genotype will be 
greater than by chance in an individual with the phenotype. 
1.3.2.1 Genome-wide association studies 
In 2002, the International HapMap Project was launched, aiming to construct a map of 
common genetic variants in the human genome (Gibbs et al., 2003). The project investigates 
the genotypes of sequencing variants, their frequencies and the link between them within 
different populations. It provides vast tag SNPs to capture large proportion of variants for 
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association study on genome-wide scale. At the same time, the high-throughput microarray 
enables the investigation of thousands of SNPs simultaneously at an inexpensive cost. A 
genome-wide association study (GWAS) genotypes a dense set of SNPs across the genome to 
investigate common variants for their links to disorders and quantitative traits (Hirschhorn 
and Daly, 2005). Compared with genome-wide linkage scan, a GWAS is more powerful for 
identifying disease-associated variants with moderate effect (Risch and Merikangas, 1996). 
Consequently, it is an efficient and powerful tool for analyzing the genetic architecture of 
complex disorders. When testing multiple SNPs on a genome-wide scale, each SNP 
represents one hypothesis. Accordingly, the significance levels should be corrected for the 
number of SNPs. Assuming a power of 0.5, the threshold of genome-wide significance is 
5×10-7. 
The first published GWAS was performed on a cohort of about 14,000 cases and 3,000 
shared controls (Burton et al., 2007). This study discovered several genome-wide associations 
(P < 5x10-7) between genotypes and human complex disorders, e.g. coronary artery disease, 
Crohn's disease, rheumatoid arthritis, bipolar disorder, type I and type II diabetes. The 
GWAS catalog (https://www.ebi.ac.uk/gwas/) was initially developed for collecting SNP-trait 
associations reported from published genome-wide association studies (Hindorff et al., 2009). 
For the past 10 years, more than 10,000 SNPs were identified to be strongly associated (P< 
5x10-8) with complex traits (Welter et al., 2014). 
In the case of IS, a GWAS of a Japanese case-control cohort identified a SNP (rs11190870) 
near LBX1 significantly associated with IS (Takahashi et al., 2011). The same case and 
control sample sets demonstrated more association The strong association of LBX1 with IS 
was replicated in Chinese and Caucasian populations (Fan et al., 2012; Gao et al., 2013; Jiang 
et al., 2012; Londono et al., 2014). Several other gene regions have been reported to show 
association with IS in Asian and Caucasian population (Kou et al., 2013; Miyake et al., 2013; 
Sharma et al., 2011), however they are not easy to replicate in other populations. 
1.4 MISSING HERITABILITY OF COMPLEX DISORDERS 
Even though linkage study and genome-wide association study have demonstrated great 
success in mapping disease-associated genes, the identification of genetic variations that 
contribute to complex disorders was becoming slow and arduous (Hardy and Singleton, 
2009). Linkage analysis provided amounts of knowledge on high-risk rare alleles underlying 
monogenic disorder. Though those variants have high penetrance, their frequencies in the 
population are extremely rare. Beyond linkage study, GWAS is based on the hypothesis that 
common disease may be caused by common variants with high to low effects (Collins et al., 
1997). However, the screening for common variants resulted in lower impact of genetic 
factors on complex traits than we expected. For example, the heritability of age-related 
macular degeneration may be 50% explained by small amount of common variants that have 
high effects (Maller et al., 2006). On the other hand, more than 40 genetic loci can only 
explain about 5% of the heritability of height (Visscher, 2008). According to the minor allele 
frequency (MAF) in the tested population, genetic variations are categorized into rare (MAF 
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< 1%), low-frequency (MAF between 1% to 5%) and common variants (MAF > 5%). If we 
look at Figure 2, monogenic disorder causative rare variants and common variants with high 
or low impact lying on the corners of the spectrum can be detected by family-based linkage 
study or GWAS. There is a large portion of low-frequency variants with moderate effect that 
cannot be covered by traditional genetic approaches. 
 
Figure 2. Feasibility of identifying genetic variants by risk allele frequency and strength of 
genetic effect (odds ratio). Most emphasis and interest lies in identifying associations with 
characteristics shown within diagonal dotted lines. Adapted from (McCarthy et al., 2008). The reprint 
permission of this figure from (Manolio et al., 2009) was granted by Nature Publishing Group. 
Mapping of susceptibility gene in complex disorder is far from a simple task. Several 
explanations have been suggested for explaining missing heritability (Manolio et al., 2009). 
Firstly, there may be more common variants with low impact on complex disorders. 
Secondly, aside from common variants, rare and low-frequency variants likely contribute to 
phenotype with large effects that are poorly detected. Thirdly, the structure variations that 
affect larger regions than point mutations are poorly captured by SNP arrays. In addition, low 
power to detect gene-gene interaction and inadequate estimation for shared environment are 
other potential sources of missing heritability. For these reasons, there is a large demand for 
developing a new technique to investigate rare and low-frequency variants, as well as 
structure variation. 
1.5 FUNCTIONAL STUDIES FOLLOWING IDENTIFICATION OF DISEASE-
CAUSATIVE GENES 
To understand the effect of genetic variants and susceptibility genes on a disorder, many 
approaches at different levels have been applied. The computational predictions based on 
experimental data are usually the first step to study the function of genetic variants. In 
addition to computational approaches, experimental investigation is more than required for 
understanding gene function. Manipulating cultured human cell lines is a standard method in 
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detecting the consequence of genetic variants and gene function in vitro. Furthermore, to 
mimic the gene regulations in vivo, animal models are widely used for studying human 
disorders. 
1.5.1 In silico 
The function of genetic variation can be predicted according to the genomic location. 
Missense, nonsense, splicing mutation and frame-shift INDEL directly change the protein 
sequence. Several tools have been developed for predicting the effect of amino acid 
substitution on protein structure and function based on machine, e.g. SIFT, PolyPhen-2 
(Adzhubei et al., 2010; Ng and Henikoff, 2001; Ramensky et al., 2002), based on either the 
conservation of homolog protein sequence or the physical property of amino acid. To 
investigate variants in non-coding regions that may be involved with regulation of gene 
expression, the information from ENCODE (Encyclopedia of DNA Elements) project can be 
employed. ENCODE provides a variety of data generated with different assays to understand 
functional elements in the human genome, including DNA methylation, transcription factor 
binding site (TFBS) and RNA binding site, etc. (Consortium, 2012b).  
1.5.2 In vivo – model organisms 
Even though the functional study in cells has provided insight into gene regulation, it cannot 
mimic the interactions between different types of cells in a living organism. Moreover, 
certain types of cell line are very difficult to culture. Therefore, it is necessary to study gene 
function and simulate the dysfunction of candidate genes in model organisms. One approach 
to perform genetic manipulation in model organisms is to make a transgenic animal by 
introducing an exogenous DNA with a genetic mutation into zygotes. Another way is to 
modify the target sequence in an endogenous gene with a mutant version. To investigate the 
consequence of deletion and translocation, a candidate gene is knocked out by site-specific 
recombination, RNAi pathway or blocking their expression by using morpholino antisense 
oligonucleotides. 
Because of its short generation time and large amount of eggs, zebrafish has become a 
principle vertebrate model for characterizing the function of genes involved in development 
and disease, especially when the sample of functional tissue is not available to access in a 
living human. To understand the function of certain susceptibility genes in dyslexia and IS, 
several studies have already been performed on zebrafish. The dyslexia candidate gene 
orthologue in zebrafish dyx1c1 proved to control cilia growth, axonemal dynein assembly and 
cilia motility (Chandrasekar et al., 2013; Tarkar et al., 2013). The zebrafish ptk7 mutants 
developed distinct spinal deformities, and later ptk7 appeared to be involved in cilia mobility 
that is required for spine morphogenesis (Grimes et al., 2016; Hayes et al., 2014). Three 
functional variants on human IS-associated POC5 were examined on the zebrafish model and 
the expression of those variant RNAs demonstrated spine deformity (Patten et al., 2015). 
Moreover, the overexpression of lbx1 homologs in zebrafish causes body axis deformation, 
including defective convergent extension movement and body curvature (Guo et al., 2016). 
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2 INTRODUCTION 
A technique developed for sequencing DNA enabled the reading of the nucleotide sequence 
of a whole gene in the 1970s (Sanger et al., 1977). This technique was applied in the HGP for 
sequencing the human genome in the 1990s, and it took more than 10 years to complete the 
HGP. The Sanger-based method was regarded as the first generation of DNA sequencing. In 
the last decade a new technique that can produce millions or billions of DNA sequence 
fragments in a short time has been innovated to replace the slow and laborious first 
generation sequencing with limited output at a high cost. Accordingly the new method is 
referred to as next generation sequencing (NGS). 
2.1 NGS PLATFORMS 
The procedure of NGS is composed of two major parts: 1) DNA template preparation and 2) 
sequencing and imaging. The first step for preparing template is fragmentation. DNA 
templates were randomly sheared into small-size fragments. For short-read NGS, the length 
of fragment ranges from 50 bp to 400 bp, depending on platform and library kit, while the 
long reads could be up to 100 or 200 kb in length for long-read NGS (Table 1). The template 
fragments were then ligated to adaptors for amplification (except SMRT method) and 
sequencing. Illumina, SOLiD and Complete Genomics platforms are employed for genetic 
and genomic studies in this thesis, so the sequencing approaches are briefly described below. 
Table 1. Brief summary of NGS platform, adapted from (Goodwin et al., 2016) 
Sequencing methods Template preparation Platforms Read length 
Sequencing by ligation 
Emulsion PCR SOLiD  (Thermo Fisher) 50-75 bp 
In-solution DNA 
nanoball generation 
Complete Genomics 
(BGI) 50-100 bp 
Sequencing by synthesis  
(cyclic reversible 
termination) 
Solid-phase bridge 
amplification Illumina 36-250bp 
Emulsion PCR Qiagen NA 
Sequencing by synthesis 
(single-nucleotide addition) 
Emulsion PCR 454 pyosequencing (Roche) Up to 1 Kb 
Emulsion PCR Ion Torrent (Thermo Fisher) 200-400 bp 
Single-molecule real-time 
(SMRT) sequencing 
Single molecule PacBio 8-12 kb 
Single molecule Nanopore Up to 200 kb 
Synthetic long-reads 
Solid-phase bridge 
amplification Illumina ~100 kb 
Emulsion PCR 10X Genomics Up to 100 kb 
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2.1.1 Illumina 
 
Figure 3. The Illumina sequencing-by-synthesis approach. Cluster strands created by bridge amplification are 
primed and all four fluorescently labeled, 3’-OH blocked nucleotides are added to the flow cell with DNA 
polymerase. The cluster strands are extended by one nucleotide. Following the incorporation step, the unused 
nucleotides and DNA polymerase molecules are washed away, a scan buffer is added to the flow cell, and the 
optics system scans each lane of the flow cell by imaging units called tiles. Once imaging is completed, 
chemicals that effect cleavage of the fluorescent labels and the 3’-OH blocking groups are added to the flow cell, 
which prepares the cluster strands for another round of fluorescent nucleotide incorporation. (Mardis, 2008) 
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In the Illumina platform, the adapted DNA templates are randomly ligated on the solid slide 
surface of a flow cell. The inside surface contains both forward and reversed primers 
complementary to the adaptors of the DNA template. Then the bridge amplification is then 
performed to enrich the spatially separated DNA template clusters (Figure 3a). After 
detaching one end of primer, the DNA clusters are sequenced by cyclic reversible termination 
approach. Four 3’-blocked deoxynucleotides (dNTPs) labeled with fluorescent and DNA 
polymerase are simultaneously added to the flow cell channel. After the incorporation of a 
dNTP to a template cluster, the emitted fluorescent is captured to determine the identity of the 
incorporated nucleotide of each cluster in the current cycle (Figure 3b). Before moving to 
next cycle, a cleavage step is performed to remove the terminus and the fluorescent label, 
together with an additional wash. 
2.1.2 SOLiD 
In the SOLiD platform, the DNA templates attached with adaptors are ligated to magnetic 
beads that are located on the glass slide. The emulsion PCR is performed to enrich the 
template sequence on beads. The sequencing by ligation approach used in SOLiD involves 
hybridization and ligation of primed template and fluorescently labeled anchor-probe with 
known base(s). DNA ligase is added to join the labeled probe to the primer where the probe 
was hybridized to the template. Those free probes are then washed away. In each cycle, the 
emitted fluorescence of ligated probe is captured for imaging the template. Unlike other 
sequencing platforms, SOLiD utilizes two-base-encoding probes, in which each ligation 
signal represents two bases of nucleotides, defined as color-space. After removing the probe-
anchor complex, a new round of hybridization and ligation cycle starts again. 
2.1.3 Complete Genomics 
Complete Genomics is an approach performing template enrichment in solution, through the 
process of rolling cycling amplification. In this case, DNA sample is processed to create a 
circular template with four distinct adaptor regions, and then amplified to generate DNA 
nanoballs that are immobilized on a flow cell (Drmanac et al., 2010). The sequencing 
procedure is similar to the SOLiD platform, but uses one-base-encoding probes, so each 
fluorescent signal can directly represent one single nucleotide. 
2.2 NGS APPLICATION 
In recent years, high-throughput NGS technology has revolutionized genetic and genomic 
studies by providing the opportunity for interrogating different properties of cellular 
processes at massive scale. It covers genome re-sequencing, whole genome and transcriptome 
de novo assembly, transriptome profiling, DNA-protein interaction, and epigenetic 
characterization. Below are three types of NGS applied in this thesis. 
2.2.1 Whole genome sequencing and exome sequencing 
Whole genome sequencing (WGS) is to determine the complete DNA sequencing of a whole 
genome of any organism at one time. Using this method, an entire human genome can be re-
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sequenced within a single day, instead of a decade spent in the HGP with Sanger-based 
sequencing. The cost of sequencing per base pair nucleotide is dramatically reduced as well 
(Metzker, 2010; Shendure and Ji, 2008). In addition to the benefits associated with the time 
and costs of sequencing whole genome, the new method also facilitates the discovery of 
novel genetic variations that cannot be accomplished by DNA arrays with pre-defined probes. 
High though-put exome sequencing was designed to re-sequence the entire exome in a human 
genome (Mamanova et al., 2010). It needs an extra step in DNA library preparation to capture 
the exons of annotated genes. Exome sequencing covers roughly 1% of the entire human 
genome (Hodges et al., 2007), and enable the target re-sequencing on more samples in a 
sequencing run with high coverage and depth at a limited cost. 
2.2.1.1 Population 
A major advantage of high though-put WGS and exome sequencing is to identify new genetic 
variations. In the dbSNP database (http://www.ncbi.nlm.nih.gov/SNP/), an increased trend in 
the total numbers of variant records has been observed over the past ten years (Figure 4).  
 
Figure 4. Rate of growth in dbSNP database and 1000 Genomes project (Human) The statistic 
summary was retrieved from the dbSNP database and publications of 1000 Genomes project 
(Consortium, 2010, 2012a; The 1000 Genomes Project Consortium, 2015). 
In 2010, the 1000 Genomes project was released, aiming to provide a characterized map of 
human genetic variations. From the WGS of 179 individuals in four populations, the exome 
sequencing of 697 individuals in seven populations and the deep sequencing of two family 
trios, 15 million SNPs, 1 million INDELs, and 20,000 structural variations were discovered 
(Consortium, 2010). The genome locations, allele frequencies in populations and haplotypes 
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were described about those variations, most of which were not annotated previously. After 
five years, the project has dramatically expanded to 2504 individuals from 26 populations, 
more than half of which have been performed whole genome and exome sequencing. The 
total numbers of genetic variants rose to 88 million (Figure 4) (Sudmant et al., 2015; The 
1000 Genomes Project Consortium, 2015). More sequencing with large sample sets on 
population levels have been performed in the UK and Iceland (Gudbjartsson et al., 2015; The 
UK10K Consortium, 2015), as well as in Finland (http://www.sisuproject.fi). The insight into 
population genetic properties of variants provided references and facilitated identifying 
variants associated with human disease in a specific population. In our case, the references of 
allele genotype and frequency in European and Finnish populations played important roles in 
filtering candidate variants for validation. 
2.2.1.2 Disorders 
Both WGS and exome sequencing have successfully identified disease-associated variants, 
especially in Mendelian disorders (Bamshad et al., 2011; Ng et al., 2010). One of the earlier 
publications using exome sequencing for identifications of disease causative genes was 
reported on a study of Freeman-Sheldon syndrome (Ng et al., 2009). High-thoughput DNA 
sequencing was also utilized for clinical or molecular diagnosis (Choi et al., 2009; Lupski et 
al., 2010). In trio studies, the exome sequencing method also helped identify de novo 
mutations associated with complex disorders (Iossifov et al., 2014; O’Roak et al., 2011; 
Sanders et al., 2012; Vissers et al., 2010). There were also several NGS studies of IS and DD. 
Exome sequencing has been performed on individual samples in families or in cohorts. Some 
rare coding variants were discovered in AKAP2, FBN1, FBN2, HSPG2, POC5 and six 
musculoskeletal collagen genes showing genome-wide significance associate with IS, 
(Baschal et al., 2015; Buchan et al., 2014; Haller et al., 2015; Li et al., 2016; Patten et al., 
2015). A novel mutation in CEP63 was identified in a Swedish family co-segregating with 
dyslexia by exome sequencing (Einarsdottir et al., 2015). A missense polymorphism in 
DCDC2 and a non-coding variant in S100B were reported to be associated with dyslexia by 
using high-throughput sequencing on candidate genes (Matsson et al., 2015). 
2.2.1.3 Pooled DNA sequencing 
WGS and exome sequencing are becoming increasingly popular in genetic studies because of 
their wide coverage and single-base resolution. However, in association study, sequencing 
each individual in the population scale is still costly, laborious and time-consuming. An 
alternative approach is to pool a number of individual DNA samples and sequence the pooled 
DNA, which can efficiently increase sample size and sequencing depth at a reduced cost and 
effort in library preparation. This approach only uses one library for entire pooled samples 
instead of separate libraries as sequencing individuals. Pooled DNA sequencing is designed 
for different purpose, such as genotype-phenotype mapping, domestication, genome 
evolution and cancer study (Schlötterer et al., 2014). The key for genotype and phenotype 
mapping is to compare the allele frequency between groups of individuals. If the individuals 
are divided into pools according to their phenotype, the phenotype-linked variants will show 
 14 
large differences in frequency between pools (Sham et al., 2002). Meanwhile, the essence of 
pooling strategy is the allele frequency estimates in a group of individuals. Therefore, pooled 
DNA sequencing is appropriate for detecting phenotype-associated variants at a large scale 
and low cost. It can be applied in WGS, exome sequencing and target sequencing on 
restriction sites. 
The pooling strategy showed good performance in fine mapping complex traits in model 
organisms (Axelsson et al., 2013; Bastide et al., 2013). Furthermore, pooled DNA sequencing 
demonstrated excellent performance in detecting rare variants when exploring candidate 
genes in human samples as well (Bansal et al., 2010; Druley et al., 2009; Out et al., 2009). In 
addition, certain pooled DNA sequencing studies at the whole exome scale have also 
discovered low-frequency variants associated with human complex disorders (Flanagan et al., 
2013; Jiao et al., 2014). 
2.2.2 RNA sequencing 
RNA sequencing, so-called “RNA-seq”, is a method to study mRNA expression levels in a 
transcriptome-wide range using deep sequencing technology. The library preparation in 
RNA-seq requires converting a population of total RNA or polyA-tailed RNA to a library of 
cDNA fragments. With or without amplification, the cDNA fragments were then sequenced 
in a high-throughput approach. Before the era of NGS, large-scale gene expression studies 
were performed using microarrays, which has limitations in accuracy of low-abundant gene 
expression measurement and background level of hybridization (Marioni et al., 2008; Wang 
et al., 2009). This technique also requires the existing knowledge of genome annotation for 
profiling the whole transcriptome. Unlike microarrays, RNA-seq does not rely on the pre-
determined probe and is thus able to detect transcription start sites, capture alternative 
splicing patterns and construct novel transcripts (Ozsolak and Milos, 2011; Wang et al., 
2009). 
RNA-seq has been applied to profiling mouse and human transcriptomes (Mortazavi et al., 
2008; Sultan et al., 2008), especially during early developmental stages at single-cell 
resolution (Töhönen et al., 2015; Xue et al., 2013; Yan et al., 2013). In addition to the 
profiling of mammalian transcriptomes, RNA-seq has been utilized for transcriptome 
characterization and genome annotation on other model organisms (Derrien et al., 2011; Derti 
et al., 2012; Tan et al., 2013). As an invaluable model organism mentioned in section 1.5, 
zebrafish was used for understanding vertebrate development and human disease. To study 
gene expression at early development, several RNA-seq studies have been performed on 
zebrafish (Aanes et al., 2011, 2013; Vesterlund et al., 2011; Yang et al., 2013), from which 
novel transcripts and isoforms were discovered before and after zygotic genome activation. In 
addition, tag-based approach, cap analysis of gene expression (CAGE), was employed to map 
the transcription initiation and predict the transcription start sites in zebrafish embryo 
development (Nepal et al., 2013). RNA-seq has provided a large volume of data for 
identifying novel transcribed regions (NTRs) and isoforms of known genes. Before RNA-seq 
was used for annotating the zebrafish genome, there were 28717 transcripts in Ensembl 
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genome annotation release 54 (reference genome Zv8) in early 2009. Until the end of 2014, 
the total number of transcripts was almost double (56754) in Ensembl genome annotation 
release 79 (reference genome Zv9). The new zebrafish genome annotation is still under 
construction based on reference genome GRCz10. The total number of transcripts has so far 
increased to 57866 (release 84). 
2.3 BIOINFORMATIC ANALYSIS OF NGS DATA 
In the Illumina platform, the raw reads generated by sequencing machine are displayed in 
FASTQ format, regarded as the standard layout format of sequencing reads. Except for the de 
novo assembly purpose, the raw reads are usually aligned to the reference genome. The 
alignment procedure is also called mapping. The color-space reads generated by SOLiD 
platform are in different formats. When performing mapping, the reference genome should be 
converted to color-space to be consistent with sequencing reads. The mapped reads are 
usually presented in SAM format and further compressed to BAM format (Li et al., 2009). 
The BAM file contains information about the mapping quality and position of short reads. 
PCR duplicate removal is usually conducted on mapped DNA sequencing reads. A best 
practice workflow recommends INDEL realignment and base quality score recalibration on 
mapped reads (DePristo et al., 2011). After the pre-processing steps, the mapped reads are 
utilized for further analysis with diversity of purpose, e.g. variant detection, gene expression 
profiling, and new transcripts identification.  
WGS and exome sequencing has been widely used in genetic research for identifying novel 
causal variants associated with rare diseases and susceptibility genes to common diseases. 
The capacity of sequencing instruments is now becoming increasingly large. A huge volume 
of both raw and analyzed data have been generated for the past several years and continue to 
increase especially when the sequencing cost drops dramatically (Goodwin et al., 2016). How 
shall we store large datasets, to evaluate the accuracy and precision, and to prioritize 
candidate genes? Data maintenance, analysis and interpretation are big challenges for 
handling NGS applications. 
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3 AIMS 
The study projects presented in the thesis focused on the application of NGS technology in 
dissecting the genetics of complex diseases and annotating the model organisms used for 
functional study. 
Paper I Assess the reliability of rare and low-frequency variant discovery and 
evaluate the accuracy of minor allele frequency estimates with pooled DNA 
sequencing 
Paper II Identify susceptibility variants to scoliosis by exome sequencing of IS 
patients with a severe phenotype 
Investigate the association of previously reported SNPs with IS in a 
Scandinavian cohort by a candidate gene study 
Paper III Find the genetic variants within previously identified susceptibility locus 
that could explain the dysfunction of ROBO1 by re-sequencing the whole 
genome 
Paper IV Discover NTRs in zebrafish by using RNA sequencing data and an in-
house pipeline 
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4 MATERIALS AND METHODS 
4.1 STUDY SUBJECTS AND MATERIALS 
4.1.1 Idiopathic scoliosis (IS) case-control cohorts 
Between 2004 and 2013, IS patients were invited to participate in the IS and Genetics in 
Scandinavia (ScoliGeneS) project (Andersen et al., 2006; Grauers et al., 2013, 2014). It is a 
multi-center study involving Karolinska University Hospital in Stockholm, Sahlgrenska 
University Hospital in Gothenburg, Sundsvall and Härnösand County Hospital, Umeå 
University Hospital and Middelfart Hospital in Denmark. Until the end of 2013, 1885 
individuals were eligible and available for inclusion in the Scoliosis and Genetics in 
Scandinavia (ScoliGeneS) project and DNA samples were successfully extracted from 1739 
of them (blood from 98% of the samples and saliva from 2% of the samples). The controls 
are composed of two cohorts: 909 elderly women from the OPRA cohort and 903 young 
women from the PEAK-25 cohort living in Malmö, Sweden (Gerdhem and Akesson, 2007; 
McGuigan et al., 2007). DNA samples were extracted from the blood of the controls. 
In Paper I and II, 100 severe IS patients in the ScoliGeneS cohort (24 male and 76 female) 
were selected for exome sequencing with pooling strategy and validation by individual 
genotyping. In Paper II, 1739 cases and 1812 controls were used for studying the association 
of LBX1 with IS by genotyping. The ethical permits for sample collection and genetic study 
were approved by the Lund university Research Ethics Committee, the Regional Ethical 
Board in Skåne, the Karolinska Institutet Research Ethics Committee, the Regional Ethical 
Board in Stockholm and the Regional Committees on Health Research Ethics for Southern 
Denmark. 
4.1.2 Preeclampsia (PE) case-control cohorts and families 
The Finnish Genetics of Pre-eclampsia Consortium (FINNPEC) case-control cohort 
(Kaartokallio et al., 2014) was collected from five Finnish university hospitals from 2008 to 
2011: Turku University Central Hospital, Oulu University Hospital, Helsinki University 
Central Hospital, University of Helsinki and Kuopio University Hospital. In Paper I, 90 
severe PE patients with early onset or high proteinuria from the FINNPEC cohort were 
selected for exome-sequencing. In addition, 10 PE patients recruited from Kainuu and 
Helsinki were also included in exome sequencing. They belong to separate families chosen 
from previous family studies (Laivuori et al., 2003; Majander et al., 2013). The genomic 
DNA was extracted from the whole blood of the 100 samples. In addition to exome 
sequencing, they were also used for validation by individual genotyping. The ethical permits 
for sample collection and genetic study were approved by the Karolinska Institutet Research 
Ethics Committee and the Coordinating Ethics Committee of The Hospital District of 
Helsinki and Uusimaa. 
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4.1.3 Affected members of a dyslexia family 
A multiplex three-generation family segregating dyslexia in an autosomal dominant fashion 
was identified in Helsinki, Finland (Nopola-Hemmi et al., 2001, 2002). All dyslexic and 
normal individuals in the family were native Finnish speakers. Twenty-one pedigree 
members affected with dyslexia were included for genotyping.  Linkage analysis found out 
19 of them shared the same haplotype on chromosome 3. In Paper III, the 19 affected 
individuals were included for whole genome sequencing using pooling strategy. In addition, 
two of them were selected for whole gnome sequencing individually. The ethical permits for 
sample collection and genetic study were approved by the Karolinska Institutet Research 
Ethics Committee and the Coordinating Ethics Committee of The Hospital District of 
Helsinki and Uusimaa. 
4.1.4 A Bull Terrier tail-chasing case-control cohort 
In a previous study about environmental effects on behavior, DNA samples were collected 
from tail-chasing Bull Terriers and controls (Tiira et al., 2012). To determine the tail-chasing 
behavior, detailed questionnaires were developed for dog owners. In Paper I, the DNA 
samples extracted from the blood of 10 Bull Terriers with tail chasing (3 male, 7 female) and 
10 Bull Terriers without such phenotype (3 male, 7 female) were selected for whole genome 
sequencing. The same materials were used for validation by individual genotyping. The 
ethical permits for DNA collection and genetic studies were approved by the Finnish 
National Animal Ethics Committee.  
4.1.5 Zebrafish embryos 
The RNA-seq was performed using zebrafish material described in previous publication 
(Vesterlund et al., 2011). In brief, the eggs were collected immediately after fertilization, 
further staged by developmental time and observations of developmental stage: 1-cell, 16-
cell, 512-cells and 50% epiboly. In each embryonic stage, total RNA was extracted from 
approximately 150 embryos. In Paper IV, we re-use the RNA-seq data for novel transcript 
identification. For experimental validation of putative NTRs, zebrafish cDNA from 50% 
epiboly was used as the template. Three biological replicates of each developmental stage 
were used for validating and measuring the expressions of randomly selected NTRs. The 
ethical permits for material collection and gene expression studies were approved by the 
Stockholm Animal Research Ethical Board. 
In order to investigate the functions of candidate genes and the effects of genetic variants on 
non-coding regions, cell lines are usually employed to test the loss or gain of putative protein 
binding site on mutated loci. In Paper III, various types of cell lines were employed for 
functional study, which are describe in detail in the published paper. 
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4.2 NEXT GENERATION SEQUENCING 
4.2.1 Pooling strategy 
In Paper I and II, every 10 of a total of 100 IS patient samples were pooled together for 
exome sequencing. The same pooling scheme was utilized in Paper I for pooling the 100 
severe PE patient samples and 20 Bull Terrier samples according to their characteristics 
(Table 2). In both exome sequencing studies of IS and PE, 800 ng of DNA extracted from 
individual samples was used for pooling. In the WGS study of Bull Terriers, 1 µg of DNA 
extracted from each Bull Terrier was used for pooling. The concentration and purity of DNA 
in the samples were controlled using a Nanodrop spectrophotometer, agarose gel 
electrophoresis and Qubit fluorometer. In Paper III, the same amount of DNA samples from 
19 dyslexic family members were pooled together for whole genome sequencing. 
Table 2. Pooling scheme for whole genome sequencing and exome sequencing 
Study Sequencing Pool #Samples Characteristic 
IS 
(Paper I, II) 
2x100bp 
paired-end 
exome 
sequencing 
1 10 Cobb angle: 54.9±10.3 from Skåne 
2 10 Cobb angle: 59.9±13 from Skåne 
3 10 Cobb angle: 54.9±9 from Skåne 
4 10 Cobb angle: 57.2±23.8 from Skåne 
5 10 Cobb angle: 54.7±8.2 from Skåne 
6 10 Cobb angle: 54.6±5.5 from Skåne 
7 10 Cobb angle: 59±19.5 from Stockholm 
8 10 Cobb angle: 55.6±9.4 from Stockholm 
9 10 Cobb angle: 56.3±17.4 from Stockholm 
10 10 Cobb angle: 55.9±9.3  from Skåne and Stockholm 
PE 
(Paper I) 
2x100bp 
paired-end 
exome 
sequencing 
1 10 Severe and early onset PE 
2 10 Severe and early onset PE 
3 10 Severe PE with proteinuria over 6g/24h 
4 10 Severe PE with proteinuria over 6g/24h 
5 10 Severe PE with previous miscarriage(s) 
6 10 Severe PE with proteinuria over 3g/24h 
7 10 Severe PE 
8 10 Severe PE 
9 10 Severe and recurrent PE 
10 10 Familial PE 
Bull Terrier 
(Paper I) 
2x100bp 
paired-end 
WGS 
1 10 Compulsive tail-chasing behavior 
2 10 Non tail-chasing 
Dyslexia 
(Paper III) 
2x100bp 
paired-end 
WGS 
1 19 Dyslexic family members  with shared haplotype 
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4.2.2 Library preparation and sequencing 
For pooled exome sequencing in Paper I and II, the pooled genomic DNA samples were 
sheared to 300bp using a Covaris S2 instrument (Covaris, MA, USA). The libraries were 
prepared using SureSelectXT Reagent kits (Agilent Technologies, CA, USA) and an Agilent 
NGS workstation according to the manufacturer's instructions (SureSelectXT Automated 
Target Enrichment for Illumina Paired-End Multiplexed Sequencing, version A). The 
SureSelectXT Human All Exon 50 Mb capture library was used for the targeted enrichment. 
Because of the high PCR duplication rate in the first round in the scoliosis DNA samples, 
technical replications were performed with the same library in eight pools.  
For pooled WGS in Paper I and III, TruSeq DNA kits (Illumina Inc., CA, USA.) were used 
for preparing DNA libraries according to the manufacturer’s instructions except for the 
following changes. An MBS 1200 pipetting station (Nordiag AB, Stockholm Sweden) was 
used for automating protocols and substitutive magnetic bead clean-up methods were used for 
purification and gel-cut (Borgstrom et al., 2011; Lundin et al., 2010). The clustering was 
performed on a cBot cluster generation system using a HiSeq paired-end read cluster 
generation kit (Illumina Inc.) The technical replication of each Bull Terrier pooled sample 
was performed WGS with a different DNA library preparation.  
In Paper I, II and III, Pooled whole genome and exome sequencing were performed on an 
Illumina HiSeq 2000 (Illumina Inc.) as paired-end reads to 100 bp at SciLifeLab Core 
Facility (Stockholm, Sweden). The base conversion was done using OLB v1.9 (Illumina 
Inc.). In Paper III, the whole genome sequencing of two dyslexic male individuals was 
performed at Complete Genomics Inc. (CGI, CA, USA) using their protocols. 
As described in the previous publication (Vesterlund et al., 2011), RiboMinus™ Eukaryote 
Kit (Thermo Fisher Scientific, MA, USA) was used for depleting rRNA from total RNA, and 
then RNA was fragmented by RNase III (Thermo Fisher Scientific) in Paper IV. Using 200 
ng of fragmented RNA as input, RNA-Seq library was constructed according to the Small 
RNA Expression Kit protocol (Thermo Fisher Scientific), and sequenced using SOLiD Opti 
Fragment Library Sequencing kit Master Mix 50 chemistry (Thermo Fisher Scientific) giving 
50 bp reads on a SOLiD System Sequencing platform version 3 plus (Thermo Fisher 
Scientific). We performed a total of three runs of RNA-seq, with two biological replicate runs 
and one technical replicate runs.  
4.3 DATA ANALYSIS 
4.3.1 Alignment of sequencing reads 
Paired-end Illumina sequence reads from pooled human samples in Paper I, III and III were 
aligned to the reference genomes with Burrows-Wheeler Aligner (BWA) (Li and Durbin, 
2009) version 0.6.1 for each pool. We used the National Center for Biotechnology 
Information (NCBI) human reference genome build 37 (GRCh37/hg19) as the reference 
genome. The same mapping software was applied for mapping Bull Terrier whole genome 
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sequencing reads with Canis lupus familiaris genome assembly CanFam3.1 as reference. 
SAMtools (Li et al., 2009) was used for PCR duplicate removal in each pool (the WES 
studies: version 0.1.18; the WGS study: version 0.1.19) (Figure 5). In Paper I and III, 
Genome Analysis Toolkit (GATK) (McKenna et al., 2010) version 2.7.2 was applied for 
local realignment and base recalibration, taking variants from dbSNP 137 as reference. For 
the whole genome sequencing on Complete Genomics platform in Paper III, the CGI 
production pipeline aligned original data to NCBI reference genome build 37 with 
Complete Genomics Analysis Tools (CGA™ Tools). 
In Paper IV, Tophat (Trapnell et al., 2009) v2.0.4 that applies Bowtie (Langmead et al., 
2009) v.0.12.8 was utilized for mapping color space reads generated by the SOLiD platform. 
Sequencing reads from three runs at four stages were individually aligned to the zebrafish 
reference genome danRer7/Zv9 assembly from Ensembl. All uniquely mapped reads with 
mapping quality (MQ) equal to or greater than 20 were applied for further analysis. 
 
Figure 5. Workflow of evaluating pooling strategy with DNA sequencing data 
4.3.2 Detection of genetic variations 
In Paper I, we applied three programs: SAMtools mpileup function (version 0.1.19), GATK 
UnifiedGenotyper (UG) module (version 2.7.2 for the WES studies and version 3.2.2 for the 
WGS study) and Freebayes (Garrison and Marth, 2012) (version 0.9.21), to detect SNVs 
(Figure 5). Besides the default diploid setting in SAMtools and GATK UG, we also applied a 
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ploidy setting of 20 when using GATK UG and Freebayes for detection. All uniquely aligned 
reads with high quality (MQ ≥ 20) from 10 pools in WES were simultaneously taken as input 
for variant detection. 
To evaluate the detection of SNV from WGS in Paper I, the genotypes of 20 dogs from the 
Illumina array (in section 4.4.1) were taken as the true condition. The measurements used are 
defined as follows:  
Sensitivity or true positive rate (TPR):  
Specificity (SPC) or true negative rate:  
Precision or positive predictive value (PPV):  
Negative predictive value (NPV):  
Accuracy (ACC):  
True positive (TP): the number of SNVs detected by both the WGS and the Illumina arrays; 
True negative (TN): the number of monomorphic loci that did not show SNVs in either the 
WGS or the Illumina array; False positive (FP): the number of SNVs detected by the WGS, 
but monomorphic in the Illumina array; False negative (FN): the number of SNVs detected 
by the Illumina array, but monomorphic in the WGS.  
In Paper II, SAMtools mpileup (version 0.1.18) was employed for detecting variants in 
pooled exome sequencing samples with default setting. The uniquely mapped reads with high 
quality (MQ ≥ 20) from 10 pools were separately taken as input for calling variants in each 
pool. In Paper III, SNV and INDEL discovery was conducted in pooled samples using the 
default setting of GATK based on high quality data (MQ ≥ 20). 
4.3.3 Evaluation of allele frequency estimates 
In Paper I, when using GATK and Freebayes with ploidy setting, the alternative allele 
frequency of every variant in each pool was estimated based on allele counts. The minor 
allele counts from genotype information were extracted in each pooled sample, and then 
divided by total alleles in the pool (n=20). The total alternative allele frequency (AAF) was 
the ratio of alternative allele counts to total allele counts (n=200). In Paper I and II, another 
approach based on read depth was also utilized for estimating the allele frequency. SAMtools, 
GATK and Freebayes supplied coverage information at each variant site. The total AAF was 
the percentage of reads supporting the alternative allele across all 10 pools. (Figure 6) 
For evaluating estimated allele frequency from WES in Paper I, root-mean-square deviation 
(RMSD) was employed to measure the difference between estimated MAF from exome 
sequencing and experimentally validated MAF by genotyping. The RMSD was calculated 
accordingly:  
TP
TP +FN
TN
FP +TN
TP
TP +FP
TN
TN +FN
TP +TF
TP +FP +TN +FN
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MAF: Experimentally validated minor allele frequency; estimated_MAF: minor allele 
frequency estimated from the exome sequencing data. In the Bull Terrier WGS study, taking 
genotypes from Illumina array as true condition, the allele frequency differences in pooled 
samples between the WGS and the Illumina array were calculated by directly comparing 
minor allele counts between the two platforms. 
4.3.4  Annotation and filtering of variants 
ANNOVAR (Wang et al., 2010) was applied for annotating the variants detected from pooled 
DNA sequencing data in Paper I, II and III. RefSeq, dbSNP and 1000 Genomes Project 
were the major data resources for variant annotation. Variants were usually categorized as 
common (AAF > 5%), low-frequency (AAF between 1% to 5%) and rare (AAF < 1%) 
according to the data from European population in 1000 Genomes project. Moreover, 
Integrative Genomics Viewer (Thorvaldsdóttir et al., 2013) and UCSC Genome Browser 
(Meyer et al., 2012) were applied for variant visualization. 
In Paper II, the steps for selecting candidate variants for validation: 
(1) Filter out SNVs in only one IS pool; 
(2) Filter out SNVs in more than one control pool of PE or obesity samples (Jiao et al., 2014); 
(3) Select missense, nonsense, and splice site rare and low-frequency SNVs; 
(4) Filtered out SNVs located in the “unreliable genes” in suspect gene list (Fajardo et al., 
2012; Ju et al., 2011); 
(5) Select SNVs on genes that were involved in skeleton, muscle or nervous system 
development or cell adhesion according to the Gene Ontology Consortium database 
(Ashburner et al., 2000); 
(6) Additionally keep SNVs not shown in control pools by manual visualization. 
In Paper III, the detected SNVs were filtered according to the following criteria:  
(1) Select SNVs within the genomic area of the dyslexia susceptibility haplotype; 
(2) Select SNVs with the same genotype in both individually sequenced samples; 
(3) Select heterozygous SNVs shared in individually sequenced samples and pooled samples; 
(4) Keep novel variants not annotated in dbSNP 137, 1000 Genomes Project (Phase 1 release) 
and SISu database (http://www.sisuproject.fi); 
(5) Select the novel SNVs located in ROBO1 gene and 1 Mb upstream region. 
INDEL filtration was similar to the strategy for SNVs, but an INDEL would be kept as long 
as it appeared in one of individuals and pooled samples.  
The prediction of protein binding on intergenic variants was conducted using TRANSFAC 
Public database (Wingender et al., 2000), JASPAR database (Mathelier et al., 2013), 
UniPROBE database (Newburger and Bulyk, 2009), and P-Match software (Chekmenev et 
al., 2005). 
RMSD = 1n (MAFi − estimated _MAFi )
2
i=1
n
∑
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4.3.5 Association analysis 
The association analysis of candidate variants in Paper II were performed using PLINK 
(Purcell et al., 2007) with chi-square test. P value and odds ratio (OR) was calculated by 
PLINK. Several subgroups were classified for association analysis:  
(1) Gender; 
(2) Cobb angle: mild (10° -30°), moderate (31° - 44°) and severe (≥	45°); 
(3) Major curve: right thoracic and “all except right thoracic” (including “left thoracic”); 
(4) Onset age: juvenile (4-9 years) and adolescent (10-20 years). 
4.3.6 Identification of NTRs  
Figure 6. Workflow of putative NTR detection using RNA-seq data. a) construction of fragments 
and clusters. D1: the distance between a putative NTR and any annotated transcribed regions; D2: the 
distance between two putative NTRs. b) Systematic workflow of NTR identification. 
In Paper IV, an in-house pipeline composed of BEDTools (Quinlan and Hall, 2010) modules 
and customized scripts was utilized for detecting NTRs. The pipeline performs two major 
tasks: constructing fragment from uniquely mapped reads and forming clusters (Figure 6b). A 
number of adjacent reads overlapped on the same strand were linked together to construct a 
fragment. A cluster was formed by a group of adjacent fragments within a certain distance 
(D2) on the same strand (Figure 6a). Parameters D1 and D2 were used for controlling the 
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formation of clusters. D1 decided the distance between a formed cluster and any annotated 
transcript. D2 decided the maximum distance between two adjacent clusters. A cluster could 
be defined as a putative NTR if it meets two criteria: 1) It contained at least two splicing 
junction sites detected by TopHat; 2) It was not annotated in Ensembl genome annotation 
release 79. In addition, NCBI zebrafish (Danio rerio) annotation releases 103 and 104 were 
also employed for further filtering the putative NTRs. In order to confirm the putative 
protein-coding genes, models of genes provided by GENSCAN (Burge and Karlin, 1997) and 
ORF predicted using FGENESH software (http://www.softberry.com) were used. Several 
other in silico data were employed as additional supporting evidence of NTRs, e.g. zebrafish 
CAGE data (Nepal et al., 2013), conservation information supplied by tBLASTn and RefSeq 
gene of other species. 
4.3.7 Gene expression 
In Paper IV, the expression levels of the discovered NTRs at all four studied developmental 
stages were measured based on the RNA-seq data from the biological replicate samples. The 
Cuffdiff module from Cufflinks 2.0.0 (Trapnell et al., 2012) was utilized for estimating gene 
expression in terms of fragments per kilobase of transcript per million mapped reads 
(FPKM). The expression profiles were presented using Gplots package in R (http://CRAN.R-
project.org/package=gplots) with the expression levels (FPKM) scaled in each NTR. 
4.4 EXPERIMENTAL VALIDATION 
4.4.1 Genotyping 
4.4.1.1 Illumina SNP array 
A group of tail-chasing Bull Terriers and controls were previously genotyped for GWAS. In 
Paper I, we utilized the genotyping data for validating the variants from WGS. The 
genotyping of 20 Bull Terriers included in the WGS was performed using Illumina Canine 
HD 173k SNP array (Illumina Inc.) by Illumina GenomeStudio (FIMM Technology Centre, 
Helsinki, Finland). 
4.4.1.2 MassARRAY system 
In Paper I and II, genotyping validation of human samples in the exome sequencing was 
conducted using iPLEX Gold chemistry and MassARRAY mass spectrometry system (Agena 
Bioscience, CA, USA). Multiplexed assays were designed using the MassARRAY Assay 
Design v4.0 Software (Sequenom, Agena Bioscience, CA, USA). Genotyping of the 100 IS 
samples was performed at the Mutation Analysis Facility (Karolinska University Hospital, 
Huddinge, Sweden), and genotyping of the 100 PE samples was performed at the Institute for 
Molecular Medicine Finland core facility (FIMM Technology Centre, University of 
Helsinki, Helsinki, Finland). 
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4.4.2 PCR 
In Paper II, to capture an extra non-coding exon and potential TSSs of LBX1 for detecting 
variants, primer pairs was designed using Primer3 (Koressaar and Remm, 2007; Untergasser 
et al., 2012). PCR amplification was performed on genomic DNA from the pooled IS samples 
with HotStarTaq Plus DNA Polymerase kit (Qiagen, Hilden, Germany). In Paper III, 
genomic DNA samples from dyslexic family members were used as the template for 
capturing the variants in ROBO1 loci and LHX2 binding site, with the same protocol of 
primer design and amplification described above.  
4.4.3 RT-PCR 
In Paper IV, four putative NTRs were selected for validation with RT-PCR. cDNA was 
synthesized using SuperScript III First-Strand Synthesis SuperMix according to the 
manufacturer’s protocol (Thermo Fisher Scientific). To amplify regions of putative NTRs, 
HotStarTaq plus DNA polymerase kit (Qiagen) was used together with specific PCR primers 
designed by Primer 3 for covering the first and the last exon of predicted isoforms. 
4.4.4 qRT-PCR 
In Paper IV, 10 NTRs were randomly selected for validation of expression in four different 
developmental stages using qRT-PCR. Expression of bactin2 in each developmental stage 
was used as the control. The primers were designed to span the exon splicing junctions by 
using Primer3 mentioned above. According to the manufacturer’s protocol, fast SYBR Green 
Master Mix (Thermo Fisher Scientific) was used for qRT-PCR and the experiments were run 
on the 7500 Real-Time PCR system (Applied Biosystems). Three biological replicates of 
each NTR in each developmental stage were used for quantitative measurement with b-actin 
as control. ΔCt was calculated as Ct of NTR minus Ct of b-actin. Average -ΔCt values were 
applied to demonstrate the expression patterns in 10 validated NTRs. ΔΔCt was calculated as 
ΔCt of each developmental stage minus ΔCt of 1-cell stage. 
4.4.5 Sanger sequencing 
In Paper II and III, all DNA amplicons were sequenced using cycle sequencing technology 
on an ABI 3730XL sequencing machine at Eurofin Genomics (Ebersberg, Germany). In 
Paper IV, cDNA fragments were subsequently cloned into pCRII-TOPO vector (Invitrogen, 
Thermo Fisher Scientific) and then sent for Sanger sequencing as described above. 
4.4.6 Functional studies 
In Paper III, an electrophoretic mobility shift assay (EMSA) was utilized for measuring 
protein and DNA binding affinity at LHX2 binding site. We then employed Luciferase assay 
to evaluate the effect of variants on gene expression level compared with wild type and 
knocked down LHX2 in lymphoblast cell lines to study the effect of LHX2 on ROBO1 gene 
expression. The protocols of those experiments were described in details in Paper III. 
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5 RESULTS 
5.1 EVALUATION OF POOLING STRATEGY (PAPER I) 
In this study, we evaluated the reliability of rare and low-frequency variant detection and 
accuracy of allele frequency estimates by using pooled DNA sequencing. 
In the IS and the PE pools, Freebayes detected a higher proportion of singleton SNVs (SNVs 
in only one pool). SAMtools had the least amount of rare variants among three tools, but 
more common variants. When looking at the target enrichment regions, 99% of the SNVs 
detected by SAMtools were covered by GATK. Freebayes detected the largest number of 
SNVs in target regions, however the majority of the Freebayes-specific SNVs had a low 
possibility of being truly polymorphic, suggestion likely false positives. Thus it is critical to 
filter out the low quality SNVs when using Freebayes for variant detection. After 
conducting genotyping on individual samples, 42 SNVs and 44 SNVs selected from the IS 
and the PE studies respectively were successfully validated. Meanwhile we found four sites 
identified as polymorphic by variants calling software was actually monomorphic in 
experimental validation. In this case, SAMtools had the lowest false-positive detection rate, 
but it missed several sites that were actually polymorphic. GATK and Freebayes had similar 
performance in variant detection. 
In each exome sequencing study, the total minor allele frequencies (MAFs) of SNVs 
estimated based on allele counts showed high similarities to the experimentally validated 
MAFs among all individuals (RMSD=0.031-0.032, Pearson correlation coefficient, r=0.88).  
Meanwhile, we also observed that the estimated MAFs were slightly exaggerated in the 
exome sequencing data. Taking the SNVs in the PE study as example, the total MAFs and 
those in each pool were overestimated for more than 50% of validated SNVs. The number of 
reads in each pool and the number of pools are found to affect the accuracy of MAF 
estimates. When excluding partial reads (20%-30%) in PE pool 7, three to four validated 
SNVs were not detected and the estimated MAFs of detected SNVs tended to be inflated. 
Randomly selecting PE pools, from one to nine pools, we calculated the difference between 
estimated and validated MAFs on a common SNV and a low-frequency SNV, and discovered 
that variant detection using more pools could lead to more precise estimates of MAFs. 
In the Bull Terrier WGS study, GATK and Freebayes detected a similar number of SNVs and 
the SNVs discovered using those tools were highly overlapped (88-90%). Taking the 
genotyping of Illumina array as a reference, the performance measurements of GATK and 
Freebayes detection using WGS were over 96%, suggesting a high concordance between 
those two platforms at a genome-wide level. When using MAFs of autosomal markers in the 
Illumina array for MAF evaluation, the MAF estimated from the WGS and the arrays showed 
a good concordance rate (77%) in two pooled samples with r=0.94. When excluding 
autosomal monomorphic markers, 43% had identical MAFs and 41% had only one allele 
difference between two platforms. Especially for the low-frequency variants in the Illumina 
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array, 56% of have identical MAFs and 26% have one allele difference between sequencing 
and individual genotyping data. 
5.2 POOLED EXOME SEQUENCING AND CANDIDATE GENE FOR STUDYING 
IS (PAPER II) 
Exome sequencing on pooled samples was conducted to identify susceptibility genes to IS, 
followed by an association validation in large cohort. The candidate gene study replicated the 
association of LBX1 with IS in the Scandinavian cohort. 
Approximately 307 to 412 million sequence reads were obtained in each pool, over 90% of 
which could be mapped to the human reference genome. Around 80-90% were covered by at 
least 30x reads. More than 1.7 million SNVs were detected from the pooled exome 
sequencing data. After variant filtering, 50 SNVs were selected for validation in 180 cases, 
including the previously exome sequenced subjects, and 245 controls, but seven of them 
failed in primer design or genotyping. The initial genotyping validated 42 SNVs and we 
selected 20 of them (OR ≥ 1.5 or ≤ 0.67) for a follow-up genotyping in another 1,567 cases 
and 1,567 controls cohorts. Combining the cases and controls from two rounds of genotyping, 
we were unable to find genome-wide significant association of any of these to IS. 
Among the four candidate variants reported from previous GWAS, only the common variant 
rs11190870, located downstream of LBX1, were validated to be strongly associated to IS in a 
Scandinavian case and control cohort (p = 7×10-18, OR = 1.53). The others demonstrated no 
or very weak association. The subgroup analyses showed rs11190870 had stronger 
association with right thoracic curve than others and with female than male. To further 
investigate the correlation between LBX1 gene and IS, we performed Sanger sequencing in 
LBX1 loci and looked into exome sequencing data. However, except a common innocent 
silent variant, there is no genetic variant in the coding region, 5’UTR, non-coding exon or the 
promoter regions of LBX1 in pooled IS samples. 
5.3 WHOLE GENOME SEQUENCING OF DYSLEXIA SUSCEPTIBILITY 
HAPLOTYPE (PAPER III) 
The discovery of this study suggested a potential explanation about the segregation of 
dyslexia in a family. 
WGS was utilized to investigate the genomic area surrounding ROBO1 on individual and 
pooled samples. The individual WGS performed high coverage with average read depth at 
more than 50x on ROBO1 region, while the coverage of pooled WGS was a bit shallow, with 
24x average read depth on ROBO1 and 1 Mb upstream region. We searched ROBO1 and 1 
Mb upstream region for unknown SNVs, INDELs and SVs. Combining the filtering and 
annotation, we discovered one intronic SNV, two intergenic SNVs and 38 INDELs that were 
not reported according to the public database. The novel intergenic INDELs appeared as 
typical microsatellite repeats, which are unlikely to have functional consequences. The 
intronic SNV was between the first non-coding exon and the first coding exon of the brain 
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specific ROBO1a (NM_002941.3) splice variant, located in a potential enhancer region 
according to the FANTOM5 promoter atlas (Andersson et al., 2014; FANTOM Consortium 
and the RIKEN PMI and CLST (DGT) et al., 2014). Certain TFBSs were predicted around 
the unknown SNVs. However, EMSA analyses using RPE-1 cell nuclear extracts did not 
support transcription factor binding to the three unknown SNVs. 
We further extended the search region to 5 Mb upstream of the ROBO1 promoter region and 
discovered an unknown SNV situated in regulatory element: a TFBS for homeobox gene, 
including LIM homeobox 2 (LHX2). A reduced expression of ROBO1 was observed after 
knocking down LHX2 in the cell lines extracted from the family members and control 
individuals, which is consistent with the co-expression pattern of LHX2 and ROBO1 observed 
in FANTOM5 database. Furthermore, we investigated the binding of LHX2 on the SNV site 
and evaluated the difference caused by alternative allele. The EMSA result suggested that 
transcription factor LHX2 has a higher affinity for the alternative allele than for the reference 
allele. In addition, the luciferase assay showed that LHX2 could bind to both the reference 
and the alternative allele, but it is hard to detect a significant difference between two alleles. 
5.4 IDENTIFICATION OF NTRS USING RNA-SEQ (PAPER IV) 
In this study, we identified de novo transcripts that have not been previously annotated in 
zebrafish early development, using relatively simple in-house bioinformatics pipelines. 
By pooling 166 million uniquely mapping reads from all four stages and all three runs of 
RNA-seq, 487,937 fragments were formed with overlapped reads or reads containing splicing 
junction sites. To avoid the discovery of known transcripts or their potential extension, 
296,628 fragments located in the reference transcriptome or less than 1 kb away were filtered 
out. The remaining 191,309 fragments formed 60,194 clusters with separating distances less 
or equal to 5 kb between fragments. After excluding cluster with less than two splicing 
junctions, there were 648 putative NTRs left for further investigation. During the course of 
the study, the zebrafish genome annotations were continuously updated. Thereafter, some of 
the putative NTRs acoording to Ensembl version 79 were subsequently annotated in NCBI 
zebrafish annotation, validating our approach for those genes. The putative NTRs were then 
checked against NCBI annotation. As a final result, 152 NTRs had not been previously 
annotated in the databases. 
Four randomly selected NTRs were validated by experiment, showing high similarity with 
the predicted structures of NTRs. Certain isoforms were not detected in 50% epiboly, 
however they may exist during other studied developmental stages. In addition to confirming 
the predicted isoforms, novel isoforms with alternative splicing patterns of the NTR were also 
discovered. 
The expression of the 152 NTRs was evaluated using RNA-seq data. Except for certian NTRs 
with high expression in 50% epiboly, more than 90% NTRs showed relatively low expression 
levels (FPKM < 1) in the four studied early developmental stages. Different expression 
patterns were discovered among them. Some NTRs demonstrated a clear upregulated pattern 
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after 512-cell stage (MBT), which may be associated with processes important for organismal 
and anatomical structure development. Many NTRs demonstrated a dynamic change of 
expression during early development, with a peak in expression levels at the 512-cell stage 
(MBT). Other NTRs showed relatively high maternal expression were expressed throughout 
MBT to subsequently diminish in 50% epiboly stage.  
Gene expression profiling by qRT-PCR was performed on 10 randomly selected NTRs. The 
expression measured by qRT-PCR replicated a similar expression profile for the 8 
downregulated NTRs. The other two were detected as downregulated at the 50% epiboly 
stage by qRT-PCR, instead of large increases at 50% epiboly from RNA-seq data. 
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6 DISCUSSION 
Pooling strategy demonstrated high reliability in detecting rare and low-frequency variants 
and high accuracy in estimating allele frequency. Despite the appealing feature of low cost 
for sequencing large number of samples, it is necessary to consider the limitations of this 
strategy when designing and analyzing pooled DNA sequencing (Schlötterer et al., 2014). 
One purpose for using pooling strategy is obtaining the MAFs among pooled samples. The 
unequal composition of individual DNA materials in a pool may result in inaccurate MAFs, 
especially at positions with shallow sequencing read depths. Moreover, sequencing errors are 
difficult to distinguish from rare or low-frequency alleles. Misalignments of divergent short 
reads are hard to identify in pooled samples and affect allele frequency estimates, especially 
for low-frequency variants. Special care should be taken when using current pooling protocol 
for detecting rare and low-frequency variants in association study. In addition, pooled DNA 
sequencing with short reads usually cannot supply haplotype information that is necessary for 
some gene burden tests depending on LD between rare variants. 
In the IS study, more than 1 million SNVs were identified in coding regions from exome 
sequencing data. However, after filtering and genotyping validation, none of the selected 
functional variants were able to show significant association with IS. Aside from our 
selection, there were still large volumes of low-frequency missense variants not involved for 
association analysis. Beyond the regions covered by exome sequencing, the majority of the 
human genome was uninvestigated, so we could lose non-coding variants or long structure 
variations that may be linked to complex disorders (Alkan et al., 2011; Andersson et al., 
2014). In addition, the limited sample size may affect the statistical power in rare or low-
frequency variant association analysis. To reach sufficient statistic power for detecting rare 
variants in exome sequencing, 10,000 samples may be required (Kiezun et al., 2012). 
However, it would be a big challenge for sample collection, especially in a small population. 
Moreover, including more cases could introduce more noise from different sub-phenotypes. 
By far, there are no other genetic variants reported to have equivalent significant association 
with IS as rs11190870. This association has been replicated in several East Asian, American 
and Scandinavian populations. Those discoveries indicate that rs11190870 may be a major 
risk factor for IS and the rest of variants may show very weak effects on IS. In such a case, 
what is a practical plan for further study?  
One approach is to continue hunting the susceptibility rare or low-frequency variants, 
probably on a genome-wide scale, e.g. sequencing multiple affected individuals in a family. 
Subsequently screening variants based on their functions, population frequencies, functional 
consequence and co-segregation in the family could narrow down the candidates. A good 
example is the discovery of IS causative gene POC5 by exome sequencing on three affected 
family members (Patten et al., 2015). However, the information described above may not be 
sufficient to distinguish the susceptibility genes in complex disorders. It would then need co-
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segregation evidence from additional family or association evidence from case-control further 
screening (Cirulli and Goldstein, 2010). 
Another option is to perform functional study for characterizing the impact of genetic variants 
on the phenotype. Taking IS as example, how intergenic rs11190870 affects the phenotype is 
hard to determine even though it has strong association with IS. This common variant is 
located at a conservative domain, 7.5 kb downstream of LBX1 that is a plausible cause for 
spinal deformity (Cheng et al., 2005; Gross et al., 2002; Jagla et al., 1995; Schäfer and Braun, 
1999). The 3’-flanking region carrying rs11190870 was recently discovered to physically 
interact with the promoter region of LBX1. It worked like an enhancer that causes a higher 
transcriptional activity of LBX1 in a human cell line (Guo et al., 2016). Guo et al. also 
performed overexpression of lbx1 homologs on zebrafish embryos and the zebrafish 
demonstrated axial developmental defects. This case highlights the value of genome 
annotation for characterizing disease-associated variants in non-coding regions. When 
filtering candidate variants for validating association, those located in non-coding regions 
with limited understanding may be neglected. However, they are probably susceptible to 
disease, e.g. enhancers distally regulated through topological associated domain (Lupiáñez et 
al., 2015). Meanwhile, a more comprehensive annotation of model organism becomes vitally 
important for studying the function of genetic variants. The emphasis on genome annotation 
has moved to determining transposons, regulatory regions, pseudogenes and ncRNA genes 
(Yandell and Ence, 2012), which can be revealed and dissected with the assistance of various 
types of high-throughput sequencing. 
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7 CONCLUSION AND FUTURE PERSPECTIVE 
Altogether, our studies utilized powerful high-throughput NGS to study the genetic basis of 
complex disorders and identify putative new transcripts for functional study in animal 
models. In Paper I, we observed that a large number of low-frequency variants were detected 
from the pooled DNA sequencing, and the estimated MAFs are highly concordance with the 
validated MAFs. Because of its reliability and accuracy, the pooling DNA sequencing could 
be a cost-efficient approach for initial screening in association study on large cohort. In 
Paper II, pooling strategy was implemented in exome sequencing for studying IS. However, 
we were unable to find evidence of a strong association in our candidate low-frequency 
variants to the phenotype. The rare variant discovered from pooled and individual whole 
genome sequencing in Paper III suggested a possible explanation for dyslexia in the family. 
Nevertheless, the potential roles of other genetic variations in the linkage regions cannot be 
excluded. In Paper IV, based on RNA-seq data, we identified 152 putative NTRs using an 
in-house pipeline. Randomly selected NTRs have been experimental validated and quantified 
during different developmental stages. The discovery of NTRs provided more information for 
characterizing the zebrafish genome and studying early development in model organisms. 
High-throughput NGS of short reads have identified thousands of rare variants that could 
contribute to the genetic basis of complex disorders. The rare variants with large effects may 
partially explain the missing heritability. In addition, other underlying factors have also been 
suggested, such as structural variation, epistasis, epigenetics and shared environment (Maher, 
2008; Manolio et al., 2009). One of the factors, large-scale structural variants, are not obvious 
to resolve by using current protocol of short DNA sequencing, especially in highly complex 
regions. The single molecule real-time sequencing would be able to sequence long reads of 
10-200 kb spanning complex or repetitive regions. It has proven to be a more effective 
method for identifying disease-relevant structural variations (Ritz et al., 2014). Another risk 
factor accounting for missing inheritability may be epigenetic modifications that alter gene 
expression but do not change DNA sequencing (Trerotola et al., 2015). NGS techniques 
provide a high-resolution map of epigenetic structure and dynamics, even at the single cell 
level (Schwartzman and Tanay, 2015; Zentner and Henikoff, 2014). 
For the past several years, high-throughput DNA sequencing has become more popular, and 
even become routine in genetic research. The advantage of rapid and high-throughput 
volumes at low cost makes the possibility of this technique as an approach for clinical use. To 
meet the increasing demands from clinics, NGS service providers have developed specific 
protocols such as Illumina’s pan-cancer screening method and Qiagen’s GeneReader 
(Goodwin et al., 2016). Targeted DNA sequencing panels are utilized for detecting somatic 
mutations in cancer genes and testing disease-causative genes on fetuses and individuals of 
reproductive age, subsequently guiding diagnosis and treatment therapy. 
Large amounts of NGS data have been produced at a dramatic growth rate in both genetic 
research and clinics (Schatz and Langmead, 2013). To reduce space for data storage, several 
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methods have been suggested: storing less, compression or cloud-based solutions. Since the 
sequencing prices have continued to drop for the past few years, reproducing whole genome 
or exome sequencing is probably a wise choice rather than spending a lot on storing huge 
datasets. The current mapping files in BAM format are still too large for storage, 
subsequently a new more compact format, CRAM, started to replace the BAM format. 
Cloud-based solution supply data upload at low cost, but analyses on cloud and data 
download are relatively expensive. Data formats differ among sequencing providers, so it 
requires standard format to facilitate NGS data sharing, as well as standardization of software 
for data analysis. Robust systems should be established to keep track of data security and 
control access to data, according to the informed consent obtained from donors and patients 
(Altman et al., 2016).  
When NGS is employed in clinics to identify novel causal variants for rare diseases and 
assess the risk of individuals for common diseases, integrative methods and bioinformatic 
approaches for precise discovery are required for translating and interpreting (Altman et al., 
2016; Lelieveld et al., 2016). The error profile for each sequencing platform should be 
evaluated for understanding their strengths and limitations, subsequently guiding the selection 
of platforms in terms of expected use. Nowadays, SMRT long-read sequencing has higher 
error rates than short-read sequencing (Goodwin et al., 2016). A combination of different 
platforms could be an option to complement each other. Furthermore, in order to decipher 
complicated NGS data, reference datasets would help recognize important genetic markers 
for potential clinical use. Currently, researchers are devoted to construct a diversity of 
disease-specific and population-based databases, such as ClinGen (Rehm et al., 2015), 
ClinVar (Landrum et al., 2016), ESP (http://evs.gs.washington.edu/EVS) and ExAC 
(http://exac.broadinstitute.org), and etc. These resources can also provide references to 
develop methods for analyzing admixed genomes and identifying medically important loci. 
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